阿托伐他汀联合神经内分泌拮抗剂治疗心衰临床分析  

Clinical analysis of atorvastatin combined with neuroendocrine antagonist in the treatment of heart failure

作　　者：储红斌 CHU Hong-bin(Langxi County Hospital,Langxi 242100,Anhui)

机构地区：[1]郎溪县医院心内科

出　　处：《安徽卫生职业技术学院学报》2019年第5期38-39,共2页Journal of Anhui Health Vocational & Technical College

摘　　要：目的:探讨阿托伐他汀联合神经内分泌拮抗剂治疗慢性心衰临床疗效。方法:将84例慢性心衰患者随机分成对照组与实验组。对照组患者使用神经内分泌拮抗剂治疗,实验组患者使用阿托伐他汀和神经内分泌拮抗剂治疗。对两组患者治疗前后心功能与收缩压、舒张压进行比较。结果:治疗前两组患者LVED、LVES、LVEF水平差异无统计学意义(P>0.05);治疗后,实验组患者LVED、LVES、LVEF水平、收缩压、舒张压、左室射血分数均显著优于对照组,差异有统计学意义(P<0.05)。结论:采用阿托伐他汀结合神经内分泌拮抗剂治疗后,疗效明显,可用于临床用药。Objective:To analyze the clinical efficacy of atorvastatin combined with neuroendocrine antagonists in the treatment of chronic heart failure.Methods:Eighty-four patients were randomly divided into control group and experimental group.Control group:treatment with neuroendocrine antagonists;experimental group:treatment with atorvastatin and neuroendocrine antagonists.Cardiac function was compared with systolic and diastolic blood pressure before and after treatment in the two groups.Results:The levels of LVED,LVES and LVEF in the two groups were not significantly different before treatment(P>0.05).After treatment,the LVED,LVES,LVEF levels,systolic blood pressure,diastolic blood pressure and left ventricular ejection fraction were significantly better than the control group.The difference was significant(P<0.05).Conclusion:After treatment with atorvastatin combined with neuroendocrine antagonists,the curative effect is obvious and can be applied for clinical use.

关 键 词：阿托伐他汀结合神经内分泌拮抗剂 慢性心衰 临床疗效 

分 类 号：R541.6[医药卫生—心血管疾病]